Skip to main content Start of content

INDU Committee Meeting

Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at

Previous day publication Next day publication
Meeting No. 37
Thursday, May 8, 2008

The Standing Committee on Industry, Science and Technology met at 11:05 a.m. this day, in Room 308, West Block, the Chair, James Rajotte, presiding.


Members of the Committee present: André Arthur, Colin Carrie, Hon. Mark Eyking, Hon. Dan McTeague, Peggy Nash, James Rajotte, Hon. Raymond Simard, Bruce Stanton, Dave Van Kesteren and Robert Vincent.


Acting Members present: Bernard Bigras for Paule Brunelle and Thierry St-Cyr for Paule Brunelle.


In attendance: Library of Parliament: Lalita Acharya, Analyst; Eleanor Fast, Analyst; Dan Shaw, Analyst.


Witnesses: Bioniche Life Sciences Inc.: Susan Goebel, E. coli Project Manager. Canada's Research-Based Pharmaceutical Companies (Rx & D): Rob Livingston, Vice-Chair, Federal Affairs Committee; Normand Laberge, Vice-President, Federal Government Affairs and Federal Provincial Territorial Relations. Canadian Generic Pharmaceutical Association: Jim Keon, President. Science, Technology and Innovation Council: Howard Alper, Chair; Heather Munroe-Blum, Member, Principal and Vice Chancellor, McGill University. Trojan Technologies: Linda Gowman, Chief Technology Officer.

Pursuant to Standing Order 108(2) and the motion adopted by the Committee on February 7, 2008, the Committee resumed its study of Canadian Science and Technology.

Susan Goebel, Jim Keon, Normand Laberge, Rob Livingston and Linda Gowman made statements and answered questions.


At 12:35 p.m., the sitting was suspended.

At 12:41 p.m., the sitting resumed.


Howard Alper and Heather Munroe-Blum made statements and answered questions.


Peggy Nash moved, — That, the Standing Committee on Industry, Science and Technology urges the Minister to extend, for an additional 30 days beyond the current 15 days scheduled to end on May 11, the consultation period for the proposed regulatory amendments to the Patented Medicines regulations of the Patent Act, published in Canada Gazette Part 1 on April 26, 2008.


The Chair ruled the proposed motion inadmissible as proper notice was not given to members of the Committee as provided in the motion adopted by the Committee.


At 2:11 p.m., the Committee adjourned to the call of the Chair.


Michelle Tittley
Clerk of the Committee

2008-09-16 4:11 p.m.